Farmako ApS — Credit Rating and Financial Key Figures
CVR number: 40143548
Ny Carlsberg Vej 80, 1799 København V
anna.kouparanis@farmako.de
Income statement (kDKK)
2019 | 2020 | 2021 | 2022 | 2023 | |
---|---|---|---|---|---|
Fiscal period length | 12 | 12 | 12 | 12 | 12 |
Net sales | |||||
Gross profit | -28.97 | -26.93 | -13.13 | -13.50 | -16.88 |
EBIT | -28.97 | -26.93 | -13.13 | -13.50 | -16.88 |
Other financial expenses | -0.00 | ||||
Pre-tax profit | -28.97 | -26.93 | -13.13 | -13.50 | -16.88 |
Net earnings | -28.97 | -26.93 | -13.13 | -13.50 | -16.88 |
Assets (kDKK)
2019 | 2020 | 2021 | 2022 | 2023 | |
---|---|---|---|---|---|
Intangible assets total | |||||
Tangible assets total | |||||
Investments total | |||||
Long term receivables total | |||||
Inventories total | |||||
Current other receivables | 33.53 | 6.85 | 6.85 | 6.85 | 6.85 |
Short term receivables total | 33.53 | 6.85 | 6.85 | 6.85 | 6.85 |
Balance sheet total (assets) | 33.53 | 6.85 | 6.85 | 6.85 | 6.85 |
Equity and liabilities (kDKK)
2019 | 2020 | 2021 | 2022 | 2023 | |
---|---|---|---|---|---|
Share capital | 50.00 | 50.00 | 50.00 | 50.00 | 50.00 |
Retained earnings | -28.97 | -55.90 | -69.03 | -82.53 | |
Profit of the financial year | -28.97 | -26.93 | -13.13 | -13.50 | -16.88 |
Shareholders equity total | 21.03 | -5.90 | -19.03 | -32.53 | -49.40 |
Non-current liabilities total | |||||
Current owed to group member | 12.75 | 25.88 | 40.88 | ||
Other non-interest bearing current liabilities | 12.50 | 12.75 | 13.13 | 13.50 | 15.38 |
Current liabilities total | 12.50 | 12.75 | 25.88 | 39.38 | 56.25 |
Balance sheet total (liabilities) | 33.53 | 6.85 | 6.85 | 6.85 | 6.85 |
Try the full version of our system for free
Create your own estimates for any company
Valuation analysis
See instructions

... and more!
No registration needed.